Ketoconazole 2% w/w Shampoo
Each gram of shampoo contains 20 milligrams of Ketoconazole.
Excipients with known effect
For a full list of excipients, see Section 6.1.
Clear, pink to orange/red, viscous solution.
Ketoconazole 2% w/w Shampoo is indicated for the treatment and prevention of seborrhoeic dermatitis, pityriasis capitis (dandruff) and pityriasis versicolor that may be associated with the fungus Pityrosporum.
For topical administration.
Adults including the elderly and adolescents:
Wet hair and scalp thoroughly with water.
Apply sufficient shampoo to produce enough lather to wash the scalp and hair, gently massage it over the entire scalp and leave for 3-5 minutes before rinsing thoroughly.
Seborrhoeic dermatitis and dandruff: Use Ketoconazole 2% w/w shampoo twice weekly for 2-4 weeks.
Prophylaxis: Use Ketoconazole 2% w/w shampoo once every 1-2 weeks
Pityriasis versicolor: Use Ketoconazole 2% w/w shampoo once daily for a maximum of 5 days.
Prophylaxis: As patches of pityriasis versicolor become more apparent on exposure to the sun. Ketoconazole 2% w/w shampoo may be used once daily for a maximum of 3 days in a single treatment course before exposure to sunshine.
Hypersensitivity to ketoconazole or any of the excipients.
In patients who have been on prolonged treatment with topical corticosteroids, it is recommended that the steroid therapy be gradually withdrawn over a period of 2 – 3 weeks, while using Ketoconazole 2% w/w shampoo, to prevent any potential rebound effect.
Ketoconazole 2% w/w shampoo may be irritating to mucous membranes of the eyes and contact with this area should be avoided. If Ketoconazole 2% w/w shampoo does get into the eyes, they should be bathed gently with cold water.
This medicine contains 5.00 mg benzyl alcohol in each g which is equivalent to 0.50 % w/w. Benzyl alcohol may cause allergic reactions and mild local irritation.
No interaction studies have been performed
Ketoconazole 2% w/w shampoo is not detected in plasma after chronic shampooing or topical application.
Ketoconazole 2% w/w shampoo is not contraindicated for pregnancy or lactation, but caution should be exercised.
The safety of Ketoconazole 2% Shampoo was evaluated in 2980 subjects who participated in 22 clinical trials. Ketoconazole 2% Shampoo was administered topically to the scalp and/or skin. Based on pooled safety data from these clinical trials, there were no ADRs reported with an incidence ≥ 1%.
The following table displays ADRs that have been reported with the use of Ketoconazole 2% Shampoo from either clinical trial or postmarketing experiences.
The displayed frequency categories use the following convention:
Very common ≥1/10
Common ≥1/100 and < 1/10
Uncommon ≥1/1,000 and <1/100
Rare ≥1/10,000, <1/1,000
Very rare <1/10,000, including isolated reports
Not known (cannot estimate from the available clinical trial data).
System Organ Class
Adverse Drug Reactions
(≥1/1,000 and <1/100)
(≥1/10,000 and <1/1,000)
Immune System Disorders
Nervous System Disorders
Infections and Infestations
Skin and Subcutaneous Tissue Disorders
Hair texture abnormal
Skin burning sensation
Hair colour changes
General Disorders and Administration Site Conditions
Application site erythema
Application site irritation
Application site pruritus
Application site reaction
Application site hypersensitivity
Application site pustules
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
In the event of accidental ingestion, supportive and symptomatic measures should be carried out. In order to avoid aspiration, neither emesis nor gastric lavage should be instigated.
Pharmacotherapeutic (ATC) Classification: D01A C08
Ketoconazole is a synthetic imidazole-dioxalane derivative. It is a broad spectrum antifungal agent which inhibits the growth of common dermatophytes and yeasts by altering the permeability of the cell membrane:
Dermatophytes: Trichophyton rubrum, T. mentagrophytes, T.tonsurans, Microsporum canis, M. audouini, M. gypseum and Epidermophyton floccosum.
Yeasts: Candida albicans, C tropicalis, Pityrosporum ovale (Malassezia ovale) and Pityrosporum orbiculare (M. furfur).
Ketoconazole was not detected in plasma in 39 patients who shampooed 4-10 times per week for 6 months or in patients who shampooed 2-3 times per week for 3-26 months. Twelve hours after a single shampoo, hair samples taken from six patients showed that high amounts of ketoconazole were present on the hair; only about 5% had penetrated into the hair keratin. There were no detectable plasma levels after chronic shampooing twice weekly for two months with ketoconazole.
There is no relevant information additional to that contained elsewhere in the Summary of Product Characteristics.
Sodium Laureth Sulfate Paste 70 %
Disodium Laureth Sulfosuccinate Liquid 40%
Citric Acid Monohydrate
Imidazolidinyl Urea (Imidurea)
Do not store above 25 °C.
Store in original container.
Keep container tightly closed.
White High-density polyethylene (HDPE) multi dose bottles with Polypropylene flip top closures.
Pack sizes: 120 ml.
Pinewood Laboratories Limited trading as Pinewood Healthcare